脑性酸酶的阻断有效地减少了粉样β斑块负担和相关的认知障碍
Lucia Soria-Tobar1,2, Laura Román-Valero1, Álvaro Sebastián-Serrano2,3
1Department of Biochemistry and Molecular Biology, Veterinary School, Complutense University of Madrid, Avda. Puerta de Hierro S/N, Madrid, 28040, Spain.
Alzheimer's research & therapy
|October 23, 2024
概括
抑制组织非特异性性酸酶 (TNAP) 降低了粉样β斑块负担和阿尔茨海默病模型中的认知衰退. 这种方法为阿尔茨海默病治疗提供了一个有希望的新策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 是一种流行的神经退行性疾病.
- 目前针对阿尔茨海默氏症的粉样β (Aβ) 向疗法在疗效和副作用方面存在局限性.
- 组织非特异性性酸酶 (TNAP) 在AD大脑中被上调,并与tau病理有关.
研究的目的:
- 研究TNAP抑制在降低阿尔茨海默病老年斑块负担中的有效性.
- 探索TNAP在Aβ相关毒性和认知障碍中的作用.
主要方法:
- 通过药理和遗传抑制,评估TNAP对脑老年性斑块负载的影响.
- 使用了死后人类AD样本,用TNAP抑制剂治疗的APP/PS1小鼠和TNAP缺乏的APP/PS1小鼠.
主要成果:
- 基因或药理TNAP阻塞通过增强Aβ清除,显著降低了老年斑块负担.
- 抑制TNAP改善了Aβ诱导的认知障碍,与增加的微质招募和细胞形成有关.
- 通过LRP1介导的机制,TNAP阻塞促进了Aβ通过血脑屏障的运输.
结论:
- 在AD模型中,TNAP抑制有效降低了脑老年斑块负担和相关的行为缺陷.
- 阻断TNAP也改善了陶诱导的神经毒性,并增加了寿命,这表明了双重的治疗效益.
- 抑制TNAP代表了阿尔茨海默病潜在的新和有效的治疗策略.
相关概念视频
01:22Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
01:26Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
101
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
101
00:49The Blood-brain Barrier
46.9K
Overview
46.9K